Prothena Corp. plc buy Chardan Capital
Start price
21.02.25
/
50%
€16.20
Target price
21.02.26
€38.18
Performance (%)
-47.53%
Price
22:26
€8.50
Summary
This prediction is currently active. The BUY prediction by Chardan_Capital for Prothena Corp. plc is performing very badly with a performance of -47.53%. This prediction currently runs until 21.02.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Prothena Corp. plc | -7.330% | -7.330% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Chardan_Capital for this prediction
In the thread Prothena Corp. plc diskutieren
Prothena Co. plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $40.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat